Menlo Park, CA, United States of America

Isabel Najera

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: Roche Palo Alto LLC, Hoffmann-La Roche Inc., Syntex (u.s.a.) Inc.. Active years: 2003-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabel Najera. Retrieved from https://idiyas.com/inventor/isabel-najera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 12.5

Average Co-Inventor Count = 7.6

ph-index = 6

Forward Citations = 390(Granted Patents)


Location History:

  • St. Albans, GB (2003)
  • Menlo Park, CA (US) (2004 - 2011)
  • Madrid, ES (2014)
  • Basel, CH (2020)

Company Filing History:


Years Active: 2003-2020

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Isabel Najera - Innovator from Menlo Park

Introduction: Isabel Najera is a pioneering inventor based in Menlo Park, CA. She is known for her groundbreaking work in various technological fields.

Latest Patents: Isabel Najera holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Isabel Najera has worked with top research institutions and leading tech companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout her career, Isabel Najera has collaborated with renowned scientists, engineers, and innovators, fostering a culture of innovation and creativity in all her projects.

Conclusion: Isabel Najera's passion for innovation and her relentless drive to push the boundaries of technology make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…